Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM.

PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e837. doi: 10.1371/journal.pntd.0000837.

2.

Inflammatory responses in Ebola virus-infected patients.

Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E.

Clin Exp Immunol. 2002 Apr;128(1):163-8.

3.

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Becquart P, Wauquier N, Mahlakõiv T, Nkoghe D, Padilla C, Souris M, Ollomo B, Gonzalez JP, De Lamballerie X, Kazanji M, Leroy EM.

PLoS One. 2010 Feb 9;5(2):e9126. doi: 10.1371/journal.pone.0009126. Erratum in: PLoS One. 2010;5(2) doi: 10.1371/annotation/9bc62f9e-8386-4e9b-951c-1eeba930a41c.

4.

Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype).

Hutchinson KL, Villinger F, Miranda ME, Ksiazek TG, Peters CJ, Rollin PE.

J Med Virol. 2001 Nov;65(3):561-6.

PMID:
11596094
5.

Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.

Gupta M, MacNeil A, Reed ZD, Rollin PE, Spiropoulou CF.

Virology. 2012 Feb 20;423(2):119-24. doi: 10.1016/j.virol.2011.11.027. Epub 2011 Dec 23.

6.

Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.

Gupta M, Goldsmith CS, Metcalfe MG, Spiropoulou CF, Rollin PE.

Virology. 2010 Jun 20;402(1):203-8. doi: 10.1016/j.virol.2010.03.024. Epub 2010 Apr 14. Erratum in: Virology. 2010 Oct 10;406(1):165. Spipopoulou, Christina F [corrected to Spiropoulou, Christina F].

7.

Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.

Hill-Batorski L, Halfmann P, Marzi A, Lopes TJ, Neumann G, Feldmann H, Kawaoka Y.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S329-35. doi: 10.1093/infdis/jiv335. Epub 2015 Jul 23.

8.

International Colloquium on Ebola Virus Research: summary report.

Breman JG, van der Groen G, Peters CJ, Heymann DL.

J Infect Dis. 1997 Oct;176(4):1058-63. No abstract available.

PMID:
9333167
9.

Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

Gupta M, Spiropoulou C, Rollin PE.

Virology. 2007 Jul 20;364(1):45-54. Epub 2007 Mar 27.

10.
11.

Immunopathogenesis of severe acute respiratory disease in Zaire ebolavirus-infected pigs.

Nfon CK, Leung A, Smith G, Embury-Hyatt C, Kobinger G, Weingartl HM.

PLoS One. 2013 Apr 23;8(4):e61904. doi: 10.1371/journal.pone.0061904. Print 2013.

12.

Functional CD8+ T cell responses in lethal Ebola virus infection.

Bradfute SB, Warfield KL, Bavari S.

J Immunol. 2008 Mar 15;180(6):4058-66.

13.

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.

Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM.

J Infect Dis. 2011 Jul 1;204(1):115-23. doi: 10.1093/infdis/jiq006. Epub 2010 Dec 14.

14.

Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.

Cross RW, Fenton KA, Geisbert JB, Mire CE, Geisbert TW.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S305-15. doi: 10.1093/infdis/jiv237. Epub 2015 Jun 2.

PMID:
26038397
15.

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V.

Immunogenetics. 2010 Dec;62(11-12):767-71. doi: 10.1007/s00251-010-0480-x. Epub 2010 Sep 29.

16.

Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species.

Pourrut X, Délicat A, Rollin PE, Ksiazek TG, Gonzalez JP, Leroy EM.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S176-83.

PMID:
17940947
17.

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.

Marzi A, Engelmann F, Feldmann F, Haberthur K, Shupert WL, Brining D, Scott DP, Geisbert TW, Kawaoka Y, Katze MG, Feldmann H, Messaoudi I.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1893-8. doi: 10.1073/pnas.1209591110. Epub 2013 Jan 14.

18.

Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.

Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, Ngoc MT, Obiang PI, Lepage JP, Bertherat EJ, Bénoni DD, Wickings EJ, Amblard JP, Lansoud-Soukate JM, Milleliri JM, Baize S, Georges-Courbot MC.

J Infect Dis. 1999 Feb;179 Suppl 1:S65-75.

PMID:
9988167
19.

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debré P, Fisher-Hoch SP, McCormick JB, Georges AJ.

Nat Med. 1999 Apr;5(4):423-6.

PMID:
10202932
20.

Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production.

Becquart P, Wauquier N, Nkoghe D, Ndjoyi-Mbiguino A, Padilla C, Souris M, Leroy EM.

BMC Infect Dis. 2010 Dec 17;10:356. doi: 10.1186/1471-2334-10-356.

Supplemental Content

Support Center